Depreciation of Perspective Therapeutics, Inc. from 30 Jun 2012 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Perspective Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2012 to 31 Mar 2024.
  • Perspective Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2024 was $346,000, a 92% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Depreciation for 2023 was $946,000, a 254% increase from 2022.
  • Perspective Therapeutics, Inc. annual Depreciation for 2022 was $267,000, a 79% increase from 2021.
  • Perspective Therapeutics, Inc. annual Depreciation for 2021 was $149,000, a 1.4% increase from 2020.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Perspective Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $346,000 +$166,000 +92% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 $180,000 +$116,000 +181% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 $68,000 +$9,000 +15% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q1 2022 $64,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $59,000 +$25,000 +74% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q3 2020 $34,000 -$4,000 -11% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q1
Q3 2019 $38,000 +$6,000 +19% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2021 Q1
Q3 2018 $32,000 +$14,000 +78% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q3 2017 $18,000 +$2,000 +12% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q1
Q3 2016 $16,000 -$120,668 -88% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2018 Q1
Q4 2015 $137,531 +$2,355 +1.7% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $136,668 -$33,302 -20% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q4 2014 $135,176 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 $169,970 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1

Perspective Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $946,000 +$679,000 +254% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $267,000 +$118,000 +79% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $149,000 +$2,000 +1.4% 01 Jul 2020 30 Jun 2021 10-KT 01 May 2023 2023 Q1
2020 $147,000 +$11,000 +8.1% 01 Jul 2019 30 Jun 2020 10-KT 01 May 2023 2023 Q1
2019 $136,000 +$56,000 +70% 01 Jul 2018 30 Jun 2019 10-K 27 Sep 2021 2021 FY
2018 $80,000 +$12,000 +18% 01 Jul 2017 30 Jun 2018 10-K 25 Sep 2020 2020 FY
2017 $68,000 -$403,000 -86% 01 Jul 2016 30 Jun 2017 10-K 27 Sep 2019 2019 FY
2016 $471,000 -$105,380 -18% 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018 2018 FY
2015 $576,380 -$109,016 -16% 01 Jul 2014 30 Jun 2015 10-K 09 Sep 2016 2016 FY
2014 $685,396 -$53,751 -7.3% 01 Jul 2013 30 Jun 2014 10-K 09 Sep 2016 2016 FY
2013 $739,147 -$107,968 -13% 01 Jul 2012 30 Jun 2013 10-K 14 Sep 2015 2015 FY
2012 $847,115 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.